Albumin is a vital protein
found in the blood plasma of mammals, making up 50-55% of plasma proteins in
humans. Synthesized in the liver, it acts as a carrier protein for various
substances including hormones, bile salts, and blood clotting factors. However,
its primary role is regulating blood volume by attracting water into the
circulatory system, particularly in the capillaries. In medical settings,
albumin is used as a plasma expander to treat shock caused by blood loss or
burns, and in emergency situations to stabilize the wounded. It also plays a
critical role in drug and vaccine production.
Although human serum albumin
(HSA) is extracted from blood plasma, natural sources are insufficient to meet
demand. Synthetic or laboratory versions of HSA have been difficult to produce,
with past attempts using potato plants and tobacco leaves proving unsuccessful.
Genetic engineering has provided new tools to produce HSA, with researchers
successfully growing HSA in rice grains after introducing a gene for encoding
HSA using bacteria (Agrobacterium) and activating it during seed production.
A green terraced rice field in Chiangmai, Thailand. |
The HSA produced in rice was
chemically and physically identical to human-derived HSA and biologically
equivalent in rats. This breakthrough has enormous implications for HSA
production, with approximately 2.8 grams of HSA produced from 1 kilogram of
brown rice, making it an extremely cost-effective method with an almost
unlimited supply. This development may help meet the demand for HSA in the
medical field, particularly in areas affected by blood loss and shock.
Keywords:
albumin, blood plasma, carrier protein, blood volume regulation, plasma
expander, shock treatment, genetic engineering, rice grain, HSA production,
cost-effective, medical field.
No comments:
Post a Comment